During CHEST 2025, contributing authors and editors will offer an inside look at recent research from the CHEST journal portfolio during the session Best of CHEST Journals, Presented by CHEST Journal, CHEST Critical Care, and CHEST Pulmonary at 8 am CT on Monday, October 20, in McCormick Place, Lakeside Center, Room 350.
“We want the CHEST membership to know that these journals are theirs,” said Matthew Miles, MD, MEd, FCCP, Editor in Chief of CHEST® Pulmonary. “The journals are editorially independent but they are also part of the American College of Chest Physicians, so we value and respond to the feedback we receive from our membership to serve them well.”
Representing CHEST Pulmonary, Rajiv Dhand, MD, MBBS, FCCP, will present “Safety, Efficacy, and Feasibility of Nebulized Long-Acting Bronchodilators vs Short-Acting Bronchodilators in Hospitalized Patients with Acute Exacerbations of COPD.” According to Dr. Miles, this article examined the effects of many hospital systems defaulting to long-acting nebulized therapies instead of short-acting alternatives when patients are admitted to the hospital for COPD exacerbations. The long-acting nebulized therapies can save time for care teams compared with short-acting nebulized therapies since they’re administered less frequently; however, researchers needed to confirm that this efficiency wasn’t coming at the expense of patients’ well-being.
“One of the major goals of our journal is to provide readers with information that informs the practice they’re giving patients today,” Dr. Miles said. “When this topic was submitted to CHEST Pulmonary, we saw the potential for immediate clinical application.”
CHEST Critical Care contributor Jeremiah Duby, PharmD, BCPS, BCCCP, will share “Mind the Gap: Estimated Duration of Inadequate Sedation After Rapid Sequence Induction and Intubation in Critically Ill Patients.”
“When this article was published, we noticed it got a lot of traction on social media,” said Hayley B. Gershengorn, MD, FCCP, Editor in Chief of CHEST Critical Care. “I think it grabbed people because it’s one of those topics that we don’t think about very much but is very important to patients.”
Dr. Gershengorn explained that the primary research question behind the study was to explore the prevalence and duration of gaps in sedation among patients who are critically ill undergoing bedside procedural paralysis.
This study also highlights the diversity of CHEST Critical Care contributors and its target audience, as the first author is a clinical pharmacist.
“We are a journal for surgical, pediatric, and trauma critical care, not just adult pulmonary critical care,” Dr. Gershengorn said. “Critical care is a team sport, so it’s important to us that [all our colleagues’] voices are heard.”
Nicola Hanania, MD, MS, FCCP, will present for the journal CHEST, reviewing important findings from a paper he helped co-author earlier this year analyzing the effects of dupilumab on health-related quality of life and respiratory symptoms in patients with COPD and type 2 inflammation.
In addition to the Best of CHEST Journals session, there will also be three “practice-changing research” sessions at the annual meeting, hosted by the journal CHEST:
- Practice-Changing Research in Critical Care, Presented by CHEST Journal at 4:30 pm on Monday, October 20, in McCormick Place, South Building, Room 403 AB
- Practice-Changing Research in Sleep, Presented by CHEST Journal at 8 am on Tuesday, October 21, in McCormick Place, Lakeside Center, Room 350
- Practice-Changing Research in Thoracic Oncology, Presented by CHEST Journal at 8 am on Wednesday, October 22, in McCormick Place, Lakeside Center, Room 350
Download the CHEST 2025 Mobile App
Start adding sessions to your meeting schedule by downloading the CHEST-Events app on your mobile device. Use the app to browse the educational program, bookmark sessions or speakers, and connect with other attendees.
